Allmedica Badania Kliniczne Sp. z o.o.

At Allmedica Badania Kliniczne Sp. z o.o. in Nowy Targ, much of the research focuses on digestive system diseases, especially Crohn’s disease, ulcerative colitis, and idiopathic or diabetic gastroparesis. These trials are designed to test new therapies and better understand how to improve symptom control, remission, and endoscopic healing in people with inflammatory bowel and gastrointestinal disorders.

• Studies in Crohn’s disease and ulcerative colitis evaluating whether new treatments can improve clinical remission and long-term disease control
• Research in inflammatory bowel disease aimed at finding better options for both induction and maintenance of response
• Trials in gastroparesis focused on easing delayed stomach emptying and related digestive symptoms

Overall, the site is contributing to research that may expand treatment choices for chronic gastrointestinal inflammation and other difficult-to-manage digestive conditions.

This site is also active in immune system diseases, with a strong emphasis on moderately to severely active inflammatory bowel disease and related immune-mediated conditions. The trials are mainly evaluating whether new immunology-based treatments can reduce inflammation, maintain response, and improve day-to-day disease outcomes.

• Studies in ulcerative colitis and Crohn’s disease testing new approaches to control immune-driven intestinal inflammation
• Research in active psoriatic arthritis exploring therapies that may better manage joint inflammation and symptoms
• Trials assessing whether emerging immunomodulatory treatments can support both short-term improvement and longer-term maintenance

With multiple ongoing investigations, Allmedica Badania Kliniczne Sp. z o.o. is helping advance research into immune-related diseases where better control of inflammation remains a key goal.

Research in skin and connective tissue diseases at this site includes studies in atopic dermatitis and venous leg ulcer, reflecting interest in both chronic inflammatory skin conditions and complex wound healing. These trials are generally aimed at evaluating new treatments that may improve skin symptoms, support healing, and enhance quality of life.

• Trials in atopic dermatitis examining whether new therapies can reduce itching, redness, and overall disease severity
• Studies in venous leg ulcer focused on improving wound debridement and preparing the wound bed for healing
• Research into inflammatory skin disease looking for better symptom control and more durable treatment benefit

This area of work highlights the site’s broader role in testing treatments for chronic conditions that affect the skin, comfort, and healing.